• Mr. S. D. Paralkar
• Dr. B. D. Tiwari
• Dr. Y. S. Thorat
• Ms. Sneha Kota
• Ms. Sweta Kota

Topical corticosteroids are the most often prescribed medications for treating a range of dermatoses (TC). Because of their potent symptom-relieving effects, these drugs are licensed for the treatment of inflammatory and pruritic symptoms of dermatologic illnesses. The most commonly used topical medication (TC) to treat skin diseases is clobetasol propionate (CP), which reduces oedema, redness, and irritation. Topical corticosteroids have vasoconstrictive, anti-inflammatory, and anti-pruritic properties. Clobetasol propionate inhibits the synthesis of inflammatory mediators and produces anti-inflammatory proteins by binding to cytoplasmic glucocorticoid receptors and activating glucocorticoid receptor-mediated gene expression. This case series discusses the efficacy, safety, and clinical experience of using CP 0.025% topical therapy to treat a variety of dermatologic conditions

Clobetasol, Cream, Dermatoses

"A COMPREHENSIVE REVIEW ON CLOBETASOL PROPIONATE CREAM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 4, page no.g391-g404, April-2024, Available :http://www.jetir.org/papers/JETIR2404652.pdf

"A COMPREHENSIVE REVIEW ON CLOBETASOL PROPIONATE CREAM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 4, page no. ppg391-g404, April-2024, Available at : http://www.jetir.org/papers/JETIR2404652.pdf